H.E. Spiegel

516 total citations
10 papers, 415 citations indexed

About

H.E. Spiegel is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, H.E. Spiegel has authored 10 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cellular and Molecular Neuroscience, 2 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in H.E. Spiegel's work include Neurotransmitter Receptor Influence on Behavior (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Metabolism and Genetic Disorders (2 papers). H.E. Spiegel is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Metabolism and Genetic Disorders (2 papers). H.E. Spiegel collaborates with scholars based in United States, Switzerland and Sweden. H.E. Spiegel's co-authors include H. J. Dengler, Myron Brin, Wayne A. Colburn, A. H. Norris, N. W. Shock, J. D. Tobin, R Andres, W Horst, Merlin G. Butler and P. György and has published in prestigious journals such as American Journal of Clinical Nutrition, Journal of Nutrition and Journal of Chromatography A.

In The Last Decade

H.E. Spiegel

10 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.E. Spiegel United States 9 130 128 74 65 42 10 415
R.A. Salvador United States 11 138 1.1× 156 1.2× 96 1.3× 18 0.3× 22 0.5× 23 547
R. Heipertz Germany 12 82 0.6× 194 1.5× 113 1.5× 13 0.2× 29 0.7× 37 401
Frederick N. Minard United States 13 188 1.4× 200 1.6× 81 1.1× 10 0.2× 31 0.7× 24 475
Demetra J. Silides United States 14 150 1.2× 184 1.4× 119 1.6× 13 0.2× 24 0.6× 24 546
J. Rosenthaler Japan 16 106 0.8× 198 1.5× 60 0.8× 17 0.3× 34 0.8× 32 788
W.A. Taylor United States 12 62 0.5× 123 1.0× 93 1.3× 13 0.2× 37 0.9× 16 489
Ella S. Haugaard United States 14 41 0.3× 291 2.3× 202 2.7× 45 0.7× 45 1.1× 29 614
Takashi Nose Japan 12 101 0.8× 198 1.5× 63 0.9× 28 0.4× 9 0.2× 59 514
Joel Dunnette United States 9 75 0.6× 122 1.0× 69 0.9× 25 0.4× 7 0.2× 18 399
I. Masi Italy 9 64 0.5× 123 1.0× 87 1.2× 23 0.4× 63 1.5× 20 312

Countries citing papers authored by H.E. Spiegel

Since Specialization
Citations

This map shows the geographic impact of H.E. Spiegel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.E. Spiegel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.E. Spiegel more than expected).

Fields of papers citing papers by H.E. Spiegel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.E. Spiegel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.E. Spiegel. The network helps show where H.E. Spiegel may publish in the future.

Co-authorship network of co-authors of H.E. Spiegel

This figure shows the co-authorship network connecting the top 25 collaborators of H.E. Spiegel. A scholar is included among the top collaborators of H.E. Spiegel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.E. Spiegel. H.E. Spiegel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gibson, Donald M., S. Cotler, H.E. Spiegel, & Wayne A. Colburn. (1985). Pharmacokinetics of Recombinant Leukocyte A Interferon Following Various Routes and Modes of Administration to the Dog. Journal of Interferon Research. 5(3). 403–408. 35 indexed citations
2.
Spiegel, H.E., et al.. (1985). Intravenous and intramuscular pharmacokinetics of recombinant leukocyte a interferon. European Journal of Clinical Pharmacology. 28(4). 469–471. 19 indexed citations
3.
Machlin, L.J., et al.. (1978). Plasma Activity of Pyruvate Kinase and Glutamic Oxalacetic Transaminase as Indices of Myopathy in the Vitamin E Deficient Rat. Journal of Nutrition. 108(12). 1963–1968. 31 indexed citations
4.
Spiegel, H.E., et al.. (1978). An improved method for determining total urinary phenol. Journal of Chromatography A. 155(1). 159–167. 8 indexed citations
5.
Boxenbaum, Harold, M. L. Jack, W. R. Dixon, et al.. (1977). Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HCl in healthy subjects: Single-dose studies by the intravenous, intramuscular, and oral routes. Journal of Pharmacokinetics and Biopharmaceutics. 5(1). 3–23. 37 indexed citations
6.
György, P., Merlin G. Butler, R Andres, et al.. (1976). Age differences in vitamin B6 status of 617 men. American Journal of Clinical Nutrition. 29(8). 847–853. 86 indexed citations
7.
Horst, W, et al.. (1973). Correlation between brain dopamine levels and l-dopa activity in anti-Parkinson tests. European Journal of Pharmacology. 21(3). 337–342. 19 indexed citations
8.
Schlosser, Walter, W Horst, H.E. Spiegel, & E.B. Sigg. (1972). Apomorphine and its effects on the spinal cord. Neuropharmacology. 11(3). 417–426. 15 indexed citations
9.
Pettinger, W. A., et al.. (1969). Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man. Clinical Pharmacology & Therapeutics. 10(5). 667–674. 21 indexed citations
10.
Dengler, H. J., et al.. (1962). The uptake of labeled norepinephrine by isolated brain and other tissues of the cat. International Journal of Neuropharmacology. 1(1-3). 23–38. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026